Padlock Therapeutics Enterprise Account Executive Salaries in Providence, RI
The average Padlock Therapeutics Enterprise Account Executive in Providence, RI earns an estimated $113,363 annually, which includes an estimated base salary of $86,320 with a $27,043 bonus. Padlock Therapeutics' Enterprise Account Executive compensation is $111 less than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Padlock Therapeutics in Providence, RI can range from $52,000 - $205,000.
In Providence, RI, The Business Development Department at Padlock Therapeutics earns $2,250 more on average than the Engineering Department.
Last updated 5 years ago.
- $86,320
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at Padlock Therapeutics
In Providence, RI, Enterprise Account Executives earn $7,531 more than Account Executives, and $3,511 less than Account Managers.
Compensation at Padlock Therapeutics by Department
In Providence, RI, The Business Development Department averages $2,250 more than the Engineering Department, and $12,866 less than the Legal Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Padlock Therapeutics reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to Padlock Therapeutics reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at Padlock Therapeutics Rate Their Compensation
The majority of Enterprise Account Executives at Padlock Therapeutics believe they're compensated fairly. 50% of Enterprise Account Executives at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics
